Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protective effects of montelukast on vancomycin-induced kidney damage
IRCT20220519054919N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of montelukast in acute kidney failure (AKF), sponsored by Arak University of Medical Sciences. Started May 2022; status: completed.
02
Drugs
montelukast
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on IRCT20220519054919N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220519054919N1.